'Dosage form' diaporamas de présentation

Pharmacology

Pharmacology. By Prof. Dr. Amany Ibrahim El-Brairy Professor of Pharmacology H107. Why we study Pharmacology?. Drug information : knowledge, skills, and attitude Rationale and safe prescribing in dental practice throughout the dental graduate career Self and continuous learner.

1.16k views • 98 slides

Welcome to Procurement & Supply Management Session Krishan Batra UNDP, New York

658 views • 44 slides

Drug Terminology Efforts in HL7

Evaluation of a Proposed Method for Representing Drug Terminology James J. Cimino, Timothy J. McNamara, Terri Meredith, Carol A. Broverman, Karen C. Eckert. Drug Terminology Efforts in HL7. Need for medication terms Much source data generated by pharmacy systems

513 views • 42 slides

Quality by Design: A Perspective From the Office of Biotechnology Products

503 views • 34 slides

Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Wa

Pharmaceutical Development. Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront Cape Town, South Africa Date: 16 to 20 April 2007. Pharmaceutical Development. Introduction to the Prequalification Programme

543 views • 34 slides

Confidentiality, Exclusivity, and Bioavailability and Bioequivalence in the Context of Pharmaceutical Data Protection

Confidentiality, Exclusivity, and Bioavailability and Bioequivalence in the Context of Pharmaceutical Data Protection and Registration of Medicines. Roger L. Williams, M.D. Chief Executive Officer United States Pharmacopeia International Seminar Intellectual Property and Access to Medicines

564 views • 32 slides

Aerosols

834 views • 32 slides

1. An Introduction to Drugs, Their Action and Discovery

1. An Introduction to Drugs, Their Action and Discovery. The basic concepts in Medicinal Chemistry. 1.1 Introduction. Primary objective ? design and discovery of new compounds that are suitable for use as drugs

664 views • 31 slides

July 2012

Pharmacy Data Management Associated Files. July 2012. Course Objectives.

368 views • 30 slides

Kill Curve Analysis

Kill Curve Analysis. Hartmut Derendorf, PhD University of Florida. Drug Delivery Pharmacokinetics Pharmacodynamics. ?. Biopharmaceutics. ?. PK-PD-Modeling. Biomarker vs. Surrogate Endpoint. Biomarker

1.08k views • 30 slides

Centre of Excellence in Biopharmaceuticals ( CoEBP ) Alan Dickson The University of Manchester

NEPIC Innovation Day, November 15 th 2011. Centre of Excellence in Biopharmaceuticals ( CoEBP ) Alan Dickson The University of Manchester. Background: Science Need CoEBP CoEBP : What can we do Success to date Future plans Contacting us. Source Evaluate Pharma 2010.

413 views • 24 slides

Look-Alike and Sound-Alike Medications Practitioner Perspectives

541 views • 20 slides

Look-Alike and Sound-Alike Medications Practitioner Perspectives

1.02k views • 20 slides

U.S. Food and Drug Administration

652 views • 19 slides

Medical Abbrevation

Medical Abbrevation. Nantawarn Kitikannakorn, B.Pharm,Pharm.D. Abbreviation Advantages. Convenience Time saver Space saver a way of avoiding the possibility of misspelling words. Abbreviation Disadvantages. Hard to understand Misread interpreted incorrectly

367 views • 15 slides

Improving Chloroquine Prescribing in Private Clinics in Lagos State, Nigeria

Improving Chloroquine Prescribing in Private Clinics in Lagos State, Nigeria *Taylor O, **Momodu RO, **Odufalu O *World Health Organisation **National Agency for Food and Drug Administration and Control (NAFDAC). Introduction/Background.

254 views • 13 slides

Introduction to pharmaceutics

Introduction to pharmaceutics. PHM224Y/PHC330Y 12.09.2005 Gregory Poon, PhD, BScPhm, RPh. Course organization. Fall term 2005. Winter term 2006. Contact information. Gregory Poon, PhD, BScPhm, RPh Ontario Cancer Institute Princess Margaret Hospital mailto://mk.poon@utoronto.ca MSN

4.09k views • 12 slides

Process Analytical Technologies An Introduction

Process Analytical Technologies An Introduction. Sheila G. Magil BioProcess Technology Consultants, Inc. Presented at Interphex New York, New York March 19, 2009. PAT is:.

410 views • 11 slides

Routes of Administration

570 views • 6 slides

Randomized Clinical Trials (RCTs)

Randomized Clinical Trials (RCTs). The protocol biasness is a factor which can led to faulty clinical results. This can be done by using different types of controls . Placebo Control

255 views • 4 slides